8:45am ET
Health and Healthcare
This Week’s Biggest Biotech Movers
This past week played host to a huge number of biotech movers. 24/7 Wall St. has picked a few of these standouts to highlight.
Chris Lange
Companies
/Healthcare
Nektar Therapeutics
$72.74
▲ $0.99 (+1.38%) today
Markets closed · 3:25am ET
NKTR Coverage
Page 2 Chris Lange 1:06pm ET
Health and Healthcare
Why This Opioid Painkiller Is Killing Nektar Therapeutics Stock
Nektar Therapeutics shares were crushed on Wednesday after the FDA did not recommend the company’s pain drug.
Chris Lange 9:35am ET
Health and Healthcare
Why This Early-Stage Autoimmune and Chronic Inflamatory Trial May Be a Big Hit
Nektar Therapeutics shares made a handy gain on Monday after the firm announced updated results from its first-in-human Phase 1a study of NKTR-358 for the treatment of autoimmune and other chronic inflammatory…
Chris Lange 8:50am ET
Investing
Top Analyst Upgrades and Downgrades: Apollo, BlackRock, Cloudflare, Green Plains, Microsoft, Oracle, Target, TJX and More
Tuesday's top analyst upgrades, downgrades and initiations included Apollo Global Management, BlackRock, Cloudflare, Green Plains, Microsoft, Oracle, Target and TJX Companies.
11:40am ET
Investing
10 Stocks Getting Crushed After Earnings
These are not the only losers after earnings, but these are the big movers to the downside that also have seen active trading on Friday after the first hour or so of…
9:05am ET
Investing
Top Analyst Upgrades and Downgrades: Activision Blizzard, ANGI, Azul, Baidu, CommScope, E*Trade, Kraft Heinz, Symantec, Uber and More
The top analyst upgrades, downgrades and initiations on Friday included Activision Blizzard, ANGI Home Services, Azul, Baidu, CommScope, E*Trade, Kraft Heinz, Symantec and Uber Technologies.
4:08pm ET
Investing
Tuesday’s Biggest Winners and Losers in the S&P 500
Tuesday was a positive day for the broad U.S. markets. All of the major exchanges had another solid performance, making this the third consecutive positive trading session amid a bear market. Crude…
9:15am ET
Investing
Top Analyst Upgrades and Downgrades: Arena Pharma, Autodesk, Coca-Cola, GE, Marvell, Monster Beverages, Nabors, Procter & Gamble and More
The top analyst upgrades, downgrades and initiations seen on Thursday included Arena Pharmaceuticals, Autodesk, Coca-Cola, General Electric, Marvell, Monster Beverages, Nabors and Procter & Gamble.
4:08pm ET
Investing
Monday’s Biggest Winners and Losers in the S&P 500
Monday was a down day for the broad U.S. markets. Each of the major exchanges started out the week on a negative note, with each seeing a loss of at least 2.0%.…
4:02pm ET
Investing
Tuesday’s Biggest Winners and Losers in the S&P 500
Tuesday was a positive day for the broad U.S. markets. Although there seemed to be a lot of uncertainty leading up to this Election Day, it seems the markets are taking it…
11:50am ET
Health and Healthcare
Nektar Therapeutics and Pfizer Team Up in Cancer Collaboration
Nektar shares dipped on Tuesday after the company announced that it would be collaborating with Pfizer to evaluate several combination regimens in multiple cancer settings.
4:08pm ET
Investing
Monday’s Biggest Winners and Losers in the S&P 500
Monday was a mixed day for the broad U.S. markets. While all three major indices started out on a positive note, only two of the three finished there. Crude oil started out…
10:45am ET
Health and Healthcare
Why Nektar Therapeutics Shares Are Tumbling
Nektar Therapeutics (NASDAQ: NKTR) saw its shares get nearly halved in Monday’s session after the company released preliminary data from its early stage cancer study. The preliminary results presented at the 2018…
7:40am ET
Health and Healthcare
Merck Wins Big Against Rivals in Lung Cancer Study Survival Rates
Lung cancer may have just met a new standard of care. On top of that, it would be considered a new standard as a first line of care in lung cancer and longer overall…
8:15am ET
Technology
Jefferies Has 4 Red-Hot Growth Stocks to Buy Despite Volatility
These four red-hot Jefferies growth stock picks could have substantial upside, especially if the market simmers down some.